Polymer/silver active bonding compound for inhibiting proliferation of activated macrophage, and preparation and applications of bonding compound
A technology of macrophages and polymers, applied in the direction of inorganic active ingredients, drug combinations, drug delivery, etc., can solve the problem of rheumatoid arthritis that does not publicly inhibit the proliferation of activated macrophages, affect the treatment effect of rheumatoid arthritis, Drug toxicity and side effects and other problems can be achieved to improve drug efficacy, relieve joint swelling and inflammation, and reduce side effects
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0067] The preparation of embodiment 1 nanometer silver preparation
[0068] Dissolve folic acid in dimethyl sulfoxide (DMSO), add DCC / NHS catalyst, the molar weight of DCC or NHS is 1.1 times that of folic acid, react at room temperature for 4 hours, and activate the carboxyl group; then add amino-modified lipoic acid-polyethylene glycol (LA-PEG 3400 -NH 2 ), reacted at room temperature for 48 hours, suction filtered, dialyzed, and freeze-dried to obtain PEG modified with folic acid (labeled as PEG-FA). Nano elemental silver and PEG-FA were mixed, and stirred at room temperature in the dark for 24 hours to obtain a polymer / silver active bond, that is, a nano silver preparation.
[0069] The particle size of the nanometer elemental silver (marked as AgNPs) of the present invention is 19-22nm, and the particle size of the nanometer silver preparation (marked as FA-AgNPs) is 31-35nm. Particle size measurement method: take the sample solution and place it in a Marlven Nano ZS ...
Embodiment 2
[0072] The stability of embodiment 2 nano silver preparations
[0073] AgNPs were mixed with different concentrations (10-200mM) of sodium chloride (NaCl) solutions. As the concentration of NaCl increased, the color of the AgNPs suspension gradually became light to colorless, and the absorbance value of the plasmon resonance absorption peak also gradually decreased. ( figure 1 D). When FA-AgNPs were mixed with different concentrations (10-200mM) of NaCl solutions, the appearance color did not change, and the absorbance value of the plasmon resonance absorption peak did not change significantly ( figure 1 E). AgNPs and FA-AgNPs were incubated with complete medium containing 10% fetal bovine serum (FBS) for 48 h at 37°C, and there was no significant change in particle size ( figure 1 F). The results showed that FA-AgNPs had good stability in NaCl solution and plasma.
[0074] Part III: Effect Measurement:
PUM
Property | Measurement | Unit |
---|---|---|
The average particle size | aaaaa | aaaaa |
Particle size | aaaaa | aaaaa |
Particle size | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com